Skip to main content
OpenTrials

Clinical trial condition

Hematologic Neoplasms

Explore clinical trials studying Hematologic Neoplasms. Study availability and eligibility vary by location and protocol.

246 public trials 47 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Neoplasms trial results

Completed

Safety and Tolerability Study of Oral NS-018 in Patients With Primary Myelofibrosis (MF), Post-polycythemia Vera MF or Post-essential Thrombocythemia MF

NCT01423851

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +14 more
Locations
  • Mayo Clinic Scottsdale Recruiting Scottsdale, Arizona, United States
  • UC San Diego Moores Cancer Center San Diego, California, United States
  • Mayo Clinic, Jacksonville Jacksonville, Florida, United States
  • Northwestern University Chicago, Illinois, United States
View Trial Details
Completed

PH 1 Study to Evaluate Safety and Tolerability of XmAb14045 in Patients With CD123-expressing Hematologic Malignancies

NCT02730312

Conditions
Acute Myelogenous Leukemia, B-cell Acute Lymphoblastic Leukemia, Blast Crisis, +39 more
Locations
  • Mayo Clinic Jacksonville Jacksonville, Florida, United States
  • Emory University Hospital Midtown Atlanta, Georgia, United States
  • Winship Cancer Institute, Emory University Atlanta, Georgia, United States
  • Blood and Marrow Transplant Group of Georgia Atlanta, Georgia, United States
View Trial Details
Completed

A Phase 2 Study of RO7490677 In Participants With Myelofibrosis

NCT01981850

Conditions
Bone Marrow Diseases, Bone Marrow Neoplasms, Fibrosis, +11 more
Locations
  • Mayo Clinic Cancer Center Phoenix, Arizona, United States
  • Stanford Cancer Institute Palo Alto, California, United States
  • Emory Hospital Atlanta, Georgia, United States
  • University of Maryland Medical Center Baltimore, Maryland, United States
View all 23 locations
View Trial Details
Completed

Study to Compare Busulfan-fludarabine With Thiotepa-fludarabine Regimen in Allogeneic Transplantation for Myelofibrosis

NCT01814475

Conditions
Bone Marrow Diseases, Bone Marrow Neoplasms, Hematologic Diseases, +8 more
Locations
  • Azienda Ospedaliera SS Antonio e Biagio Alessandria, Italy
  • Clinica di Ematologia - Ospedali Riuniti di Ancona Ancona, Italy
  • Divisione di Ematologia - Ospedali Papa Giovanni XXIII Bergamo, Italy
  • AO Spedali Civili di Brescia- USD - TMO Adulti Brescia, Italy
View all 21 locations
View Trial Details
Completed

Ruxolitinib Efficacy and Safety in Patients With HU Resistant or Intolerant Polycythemia Vera vs Best Available Therapy.

NCT02038036

Conditions
Bone Marrow Diseases, Bone Marrow Neoplasms, Hematologic Diseases, +6 more
Locations
  • Novartis Investigative Site Herston, Queensland, Australia
  • Novartis Investigative Site Antwerp, Belgium
  • Novartis Investigative Site Leuven, Belgium
  • Novartis Investigative Site Toronto, Ontario, Canada
View all 48 locations
View Trial Details
Completed

PD-1 Inhibition in Advanced Myeloproliferative Neoplasms

NCT03065400

Conditions
Bone Marrow Diseases, Bone Marrow Neoplasms, Chronic Phase Myelofibrosis, +9 more
Locations
  • Harvard Medical School Massachusetts General Hospital Boston, Massachusetts, United States
  • Icahn School of Medicine at Mount Sinai New York, United States
  • Montefiore Medical Center Division of Hematology, Department of Oncology The Bronx, New York, United States
View Trial Details

Related conditions